There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
| Orders | Qty | Bid |
|---|---|---|
| 1 | 2 | 835.05 |
| 1 | 4 | 835 |
| 1 | 8 | 834.9 |
| 2 | 9 | 834.8 |
| 3 | 17 | 834.7 |
| Ask | Qty | Orders |
|---|---|---|
| 835.5 | 6 | 15 |
| 835.55 | 1 | 2 |
| 835.6 | 1 | 6 |
| 835.65 | 2 | 3 |
| 835.7 | 2 | 12 |
Annual Revenue,rose 10.2%, in the last year to ₹7,399.31 Cr. Its sector's average revenue growth for the last fiscal year was 12.14%.Annual Net Profit,rose 15.66% in the last year to ₹674.77 Cr. Its sector's average net profit growth for the last fiscal year was 2.15%.Price to Earning Ratio,is 24.34, lower than its sector PE ratio of 42.76.Alembic Pharmaceuticals Limited is involved in manufacturing and marketing of India Formulations, International Generics, and Active Pharmaceutical Ingredients with vertical integration capabilities. Headquartered in Vadodara, Gujarat. It is the flagship company of the pioneering Alembic Group.
Close to 40% of its revenues are generated from the US generics business, while 18% of its business comes from third-party API sales. The company’s capabilities also extend to making oral solid injectables in Oncology, general complex injectables and ophthalmology. The company’s manufacturing facility in Sikkim is dedicated for manufacturing its India Formulations.
The intraday low for Alembic Pharmaceuticals Ltd on the NSE today was ₹821.30. The stock's 52-week low stands at ₹635.80, recorded on 23 Mar 2026. Today's low is 29.18% above the 52-week low, indicating the stock is trading well above its yearly lows.
Alembic Pharmaceuticals Ltd has delivered -16.63% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹1,044.80 on 15 Jul 2025 and a 52-week low of ₹635.80 on 23 Mar 2026. It is currently trading at ₹835.10 as of 07 Jul 2026.
The all-time high (ATH) for Alembic Pharmaceuticals Ltd was ₹1,247.70, recorded on 11 Sep 2024. At the current price of ₹835.10, the stock is trading 33.07% below its all-time high. The all-time low recorded was ₹35.05 on 02 Jan 2012.
Alembic Pharmaceuticals Ltd has delivered a -15.27% absolute return over the past 5 years, equivalent to a CAGR of -3.26% per annum. The stock was priced at ₹985.60 in Jul 2021 and has fallen to ₹835.10 as of 07 Jul 2026. An investment of ₹1,00,000 in Alembic Pharmaceuticals Ltd five years ago would be worth ₹84,730.00 today.
Yes,Alembic Pharmaceuticals Ltd has declared a consistent dividend every year over the past 5 years. The company paid a total dividend of 62.00 per share between FY2022 and FY2026, with the most recent dividend of ₹12.00 per share for May 26. At the current market price of ₹835.10, the trailing dividend yield of Alembic Pharmaceuticals Ltd stands at 11.00%.
Over the last 6 months, Alembic Pharmaceuticals Ltd has given a return of 1.45%. The stock was priced at ₹823.70 on 07 Jan 2026 and has Rise to ₹835.10 as of 07 Jul 2026, a change of ₹11.40 per share.
As of 07 Jul 2026, the share price of Alembic Pharmaceuticals Ltd is ₹835.10 on the NSE and ₹834.55 on the BSE. The stock opened at ₹838.00, touched a high of ₹841.95 and a low of ₹821.30 during today's session.
Alembic Pharmaceuticals Ltd has delivered a return of 21.09% over the last 3 months. The stock was trading at ₹690.10 on 07 Apr 2026 and is currently at ₹835.10 as of 07 Jul 2026, reflecting a Gain of ₹145.00 per share over this period.
For Q4 FY26, Alembic Pharmaceuticals Ltd reported: Revenue (Net Sales): ₹17187.40 Cr - Up 4.66% year-on-year from ₹16422.40 Cr in Q3 FY26. Net Income (PAT): ₹2430.70 Cr - Up 112.34% year-on-year from ₹1144.70 Cr in Q3 FY26.
The intraday high for Alembic Pharmaceuticals Ltd on the NSE today (07 Jul 2026) was ₹841.95. This compares to the 52-week high of ₹1,044.80 recorded on 15 Jul 2025. Today's high was -19.42% below the 52-week high.
